Patents by Inventor Pascal Prinderre

Pascal Prinderre has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10034883
    Abstract: The present invention is directed to a new pharmaceutical dosage form comprising mesoporous particles loaded with a poorly soluble active pharmaceutical ingredient, the particles being at least partially, preferably homogeneously, covered with a polymer solid dispersion.
    Type: Grant
    Filed: November 6, 2014
    Date of Patent: July 31, 2018
    Assignee: SIEGFRIED AG
    Inventor: Pascal Prinderre
  • Publication number: 20160263123
    Abstract: The present invention is directed to a new pharmaceutical dosage form comprising mesoporous particles loaded with a poorly soluble active pharmaceutical ingredient, said particles being at least partially, preferably homogeneously, covered with a polymer solid dispersion.
    Type: Application
    Filed: November 6, 2014
    Publication date: September 15, 2016
    Inventor: Pascal PRINDERRE
  • Patent number: 9060930
    Abstract: The present disclosure relates to a novel process for making oral solid gastro-retentive forms, including the steps of providing a powder mixture including a hydrophobic powder, overgranulating this powder mixture with a granulating solution into an overgranulated paste, and drying all paste into a solid, as well as to pharmaceutical solid dosage forms which are retained in the stomach or upper gastrointestinal tract for a controlled delivery of a drug.
    Type: Grant
    Filed: June 8, 2009
    Date of Patent: June 23, 2015
    Assignee: UNIVERSITE DE LA MEDITERRANEE
    Inventors: Pascal Prinderre, Christophe Sauzet
  • Publication number: 20120021009
    Abstract: The present disclosure relates to a novel process for making oral solid gastro-retentive forms, including the steps of providing a powder mixture including a hydrophobic powder, overgranulating this powder mixture with a granulating solution into an overgranulated paste, and drying all paste into a solid, as well as to pharmaceutical solid dosage forms which are retained in the stomach or upper gastrointestinal tract for a controlled delivery of a drug.
    Type: Application
    Filed: June 8, 2009
    Publication date: January 26, 2012
    Applicant: Universite De La Mediterranee
    Inventors: Pascal Prinderre, Christophe Sauzet